CD8A and colorectal cancer: ,59,60 Similarly, TILs were found to be beneficial in colorectal cancer, leading to the well-known example Immunoscore, which measures tumour CD3+ and CD8+ lymphocyte density and has been incorporated into the current staging system (TNM-I).24